Endonovo Therapeutics (OTCMKTS:ENDV) Stock Price Passes Above Fifty Day Moving Average – Here’s What Happened

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Endonovo Therapeutics shares last traded at $0.00, with a volume of 0 shares trading hands.

Endonovo Therapeutics Stock Down 100.0%

Endonovo Therapeutics Company Profile

Endonovo Therapeutics is a clinical‐stage biomedical company focused on developing non‐invasive therapeutic devices designed to modulate the immune system and promote tissue repair. The company’s proprietary Modulated Electrostatic Field (MEF) technology delivers pulsed energy to target inflammatory pathways and support cellular regeneration. Endonovo is primarily engaged in research and development aimed at treating conditions such as traumatic brain injury, hemorrhagic shock and acute inflammatory responses that currently have limited pharmaceutical options.

At the core of Endonovo’s platform is a portfolio of portable devices that generate precisely calibrated electrostatic fields to influence cellular behavior and accelerate the body’s natural healing processes.